Longitudinal changes in peak urinary flow rates in a community based cohort

Journal of Urology

Volumn 163, Issue 1, 2000, Pages 107-113

  Roberts, Rosebud O ^a   Jacobsen, Steven J ^b   Jacobson, Debra J ^b   Rhodes, Thomas ^b   Girman, Cynthia J ^b   Lieber, Michael M ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Cohort studies; Epidemiology; Prostatic hyperplasia; Urination

Indexed keywords

ADULT; AGED; AGING; ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY; SYMPTOMATOLOGY; URINARY TRACT INFECTION; URINE FLOW RATE; UROFLOWMETRY;

EID: 0033992104     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67984-0     Document Type: Article

References (46)

1. Barry M. J., Cockett A. T. K., Holtgrewe H. L. et al: Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol, 150: 351, 1993.
2. Ball, A. J. and Smith, P. J. B.: The long-term effects of prostatectomy: a uroflowmetric analysis. J Urol, 128: 538, 1982.
3. Walden, M., Dahlstrand, C., Schafer, W. et al: How to select patients suitable for transurethral microwave thermotherapy: a systematic evaluation of potentially predictive variables. Br J Urol, 81: 817, 1998.
4. Roehrborn, C. G.: The Agency for Health Care Policy and Research: clinical guidelines for the diagnosis and treatment of benign prostatic hyperplasia. Urol Clin North Am, 22: 445, 1995.
5. Kelly, M. J., Roskamp, D. and Leach, G. E.: Transurethral incision of the prostate: a preoperative and postoperative analysis of symptoms and urodynamic findings. J Urol, 142: 1507, 1989.
6. Campo, B., Bergamaschi, F., Corrada, P. et al: Transurethral needle ablation (TUNA) of the prostate: a clinical and urodynamic evaluation. Urology, 49: 847, 1997.
7. Larson, T. R., Blute, M. L., Bruskewitz, R. C. et al: A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology, 51: 731, 1998.
8. Homma, Y., Imajo, C. and Kawabe, K.: Maximum flow rate - the single uroflowmetric parameter in clinical trials for benign prostatic hyperplasia? Int J Urol, 2: 322, 1995.
9. Shoukry, I., Susset, J. G., Elhilali, M. M. et al: Role of uroflowmetry in the assessment of lower urinary tract obstruction in adult males. Br J Urol, 47: 559, 1975.
10. Gleason, D. M., Bottaccini, M. R., Drach, G. W. et al: Urinary flow velocity as an index of male voiding function. J Urol, 128: 1363, 1982.
11. Matzkin, H., van der Zwaag, R., Chen, Y. et al: How reliable is a single measurement of urinary flow in the diagnosis of obstruction in benign prostatic hyperplasia? Br J Urol, 72: 181, 1993.
12. Hansen, F., Olsen, L., Atan, A. et al: Pressure-flow studies: an evaluation of within-testing reproducibility - validity of the measured parameters. Neurourol Urodyn. 16: 521, 1997.
13. Reynard, J. M., Peters, T. J., Lim, C. et al: The value of multiple free-flow studies in men with lower urinary tract symptoms. Br J Urol, 77: 813, 1996.
14. Drach, G. W. and Steinbronn, D. V.: Clinical evaluation of patients with prostatic obstruction: correlation of flow rates with voided, residual or total bladder volume. J Urol, 135: 737, 1986.
15. Prescott, R. J. and Garraway, W. M.: Regression to the mean occurs in measuring peak urinary flow. Br J Urol, 76: 611, 1995.
16. Sech, S. M., Montoya, J. D., Bernier, P. A. et al: The so-called "placebo effect" in benign prostatic hyperplasia treatment trials represents partially a conditional regression to the mean induced by censoring. Urology, 51: 242, 1998.
17. Chancellor, M. B., Blaivas, J. G., Kaplan, S. A. et al: Bladder outlet obstruction versus impaired detrusor contractility: the role of uroflow. J Urol., 145: 810, 1991.
18. Barry, M. J., Fowler, F. J., Jr., O'Leary, M. P. et al: Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of the American Urological Association. Med Care, suppl., 33: AS145, 1995.
19. Holm, H. H.: A uroflowmeter and a method for combined pressure and flow measurement. J Urol, 88: 318, 1962.
20. Sciarra, A., D'Eramo, G., Casale, P. et al: Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia. Prostate, 34: 121, 1998.
21. Girman, C. J., Panser, L. A., Chute, C. G. et al: Natural history of prostatism: urinary flow rates in a community-based study. J Urol, 150: 887, 1993.
22. Guess, H. A.: Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am, 22: 247, 1995.
23. Bosch, J. L., Hop, W. C., Kirkels, W. J. et al: The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol, 75: 622, 1995.
24. McConnell, J. D., Barry, M. J., Bruskewitz, R. C. et al: Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guideline, Number 8. AHCPR Publication No. 94-0582. Rockville, Maryland: Agency for Health Care Policy and Research. Public Health Services, U. S. Department of Health and Human Services, 1994.
25. Jacobsen, S. J., Girman, C. J., Guess, H. A. et al: Natural history of prostatism: longitudinal changes in voiding symptoms in community-dwelling men. J Urol, 155: 595, 1996.
26. Rhodes, T., Girman, C. J., Jacobsen, S. J. et al: Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol, 161: 1174, 1999.
27. Guess, H. A., Jacobsen, S. J., Girman ,C. J. et al: The role of community-based longitudinal studies in evaluating treatment effects. Example: benign prostatic hyperplasia. Med Care, suppl., 33: AS26, 1995.
28. Chute, C. G., Panser, L. A., Girman, C. J. et al: The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol, 150: 85, 1993.
29. Jacobsen, S. J., Guess, H. A., Panser, L. et al: A population-based study of health care-seeking behavior for treatment of urinary symptoms: Olmsted County study of urinary symptoms and health status among men. Arch Fam Med, 2: 729, 1993.
30. Oesterling J. E., Jacobsen S. J., Chute C. G. et al: Serum prostate specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA, 170: 860, 1993.
31. Rhodes, T., Tsukamoto, T., Jacobsen, S. J. et al: Re: Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries (letter to the editor). J Urol, 158: 551, 1997.
32. Barry, M. J., Fowler, F. J., Jr., O'Leary, M. P. et al: The American Urological Association symptom index for benign prostatic hyperplasia. J Urol, 148: 1549, 1992.
33. Terris, M. K. and Stamey, T. A.: Determination of prostate volume by transrectal ultrasound. J Urol, 145: 984, 1991.
34. Jacobsen, S. J., Jacobson, D. J., Girman, C. J. et al: Treatment for benign prostatic hyperplasia among community-dwelling men: the Olmsted County study of urinary symptoms and health status among men. J Urol, 162: 1301, 1999.
35. Pearson, J. D., Morrell, C. H., Landis, P. K. et al: Mixed-effects regression models for studying the natural history of prostate disease. Stat Med, 13: 587, 1994.
36. Ware, J. H.: Linear models for the analysis of longitudinal studies. Am Stat, 39: 95, 1985.
37. Jacobson, D. J., Jacobsen, S. J., Girman, C. J. et al: Effect of sample characteristics and size on estimates of the association between prostate volume and American Urological Association symptom index scores. J Urol, suppl., 159: 138, abstract 523, 1998.
38. Jacobsen, S. J., Jacobson, D. J., Girman, C. J. et al: Natural history of prostatism: risk factors for acute urinary retention. J Urol, 158: 481, 1997.
39. Koyanagi, T., Artibani, W., Correa, R. et al: Initial diagnostic evaluation of men with lower urinary tract symptoms. In: Proceedings of the 4th International Consultation on Benign Prostatic Hyperplasia (BPH), vol. 4. Edited by L. Denis, K. Griffiths, S. Koury et al. United Kingdom: Plymbridge Distributors, Ltd., p. 209, 1998.
40. Cockett, A. T. K., Khoury, S., Aso, Y. et al: Proceedings of The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Channel Islands: Scientific Communication International Ltd., 1993.
41. Berry, S. J., Coffey, D. S., Walsh, P. C. et al: The development of human benign prostatic hyperplasia with age. J Urol, 132: 474, 1984.
42. Rhodes, T., Girman, C. J., Jacobsen, S. J. et al: Longitudinal measures of prostate volume in a community-based sample: 3.5 years followup in the Olmsted County study of health status and urinary symptoms among men. J Urol, suppl., 153: 301A, abstract 291, 1995.
43. Blaivas, J. G.: Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation. Urol Clin North Am, 17: 543, 1990.
44. Elbadawi, A., Yalla, S. V. and Resnick, N. M.: Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J Urol, 150: 1657, 1993.
45. Elbadawi, A., Yalla, S. V. and Resnick, N. M.: Structural basis of geriatric voiding dysfunction. IV. Bladder outlet obstruction. J Urol, 150: 1681, 1993.
46. Grino, P. B., Bruskewitz, R., Blaivas, J. G. et al: Maximum urinary flow rate by uroflowmetry: automatic or visual interpretation. J Urol, 149: 339, 1993.